Skip to content

Role of ayurvedic drug orally and through nasal administration in adolescent migraine.

Comparative clinical study to evaluate the efficacy of aparajita siddha ghrita as pratimarsha nasya v/s shamana snehapana in ardhavbhedaka w.s.r. adolescent migraine - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055575
Enrollment
60
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G43C- Periodic headache syndromes in child or adult

Interventions

None listed

Sponsors

Dr Namrata Nandkumar Kamble
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - A diagnosis of migraine with aura and migraine without aura - children having throbbing headache, sensitivity to light, sound, irritable, moody, nausea/vomiting - children fulfilling the ped MIDAS criteria for diagnosis of adolescent migraine.

Exclusion criteria

Exclusion criteria: - children not fulfilling the ped MIDAS criteria for diagnosis of adolescent migraine. - known case of C.P. , M.R. and epilepsy, sleep disorder. - known case of hearing deficit

Design outcomes

Primary

MeasureTime frame
Relief from subjective assesment criteria i.e. clinical sings & symptoms of ardhavbhedaka such as ardha murdha (half sided headache) , frequency , prakash asahtva (photophobia) , dhwani asahatva (phonophobia), bhrama (giddiness), shirataap ( local temperature), chardi ( vomittingTimepoint: Base line , after 15 days for 90 days trial

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Kalpana Dhuri

DY Patil School of Ayurved and Hospital nerul navi mumbai

dhurikalpana34@gmail.com9321835616

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026